SCHEMBL12422006

SCHEMBL12422006

Cc1ccc2nc(-c3ccc(NC(=O)c4ccc(N(C)C)cc4C)cc3)sc2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 3/20 0.63
MAPT P10636 12/20 0.61
TP53 P04637 5/20 0.61
LMNA P02545 2/20 0.59
SMN1; SMN2 Q16637 4/20 0.58
KDM4E B2RXH2 8/20 0.57
NPC1 O15118 8/20 0.57
RAB9A P51151 8/20 0.57
ALDH1A1 P00352 7/20 0.57
HPGD P15428 5/20 0.57
MEN1 O00255 4/20 0.57
KMT2A Q03164 4/20 0.57
NPSR1 Q6W5P4 3/20 0.57
HTT P42858 1/20 0.57
RXFP1 Q9HBX9 1/20 0.57
GAA P10253 1/20 0.55
CASP3 P42574 1/20 0.55
SENP8 Q96LD8 1/20 0.55
SENP7 Q9BQF6 1/20 0.55
SENP6 Q9GZR1 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1073362 0.89 MAPT (0.70) APPMAPTTP53LMNASMN1; SMN2
SCHEMBL12509470 0.89 APP (0.64) APPMAPTTP53SMN1; SMN2KDM4E
SCHEMBL12422004 0.86 MAPT (0.63) APPMAPTTP53LMNASMN1; SMN2
SCHEMBL6227082 0.84 MAPT (0.76) APPMAPTTP53LMNASMN1; SMN2
SCHEMBL2196588 0.84 MAPT (0.80) APPMAPTTP53LMNASMN1; SMN2
SCHEMBL12422193 0.84 MAPT (0.67) APPMAPTTP53LMNASMN1; SMN2
SCHEMBL2191266 0.83 MAPT (0.71) MAPTTP53LMNASMN1; SMN2KDM4E
SCHEMBL12422008 0.82 MAPT (0.59) APPMAPTTP53LMNASMN1; SMN2
SCHEMBL1071608 0.82 MAPT (0.67) APPMAPTTP53LMNASMN1; SMN2
SCHEMBL12980051 0.82 MAPT (0.67) APPMAPTTP53LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895313-B2 Ligands for aggregated tau molecules WISTA LABORATORIES LTD. (SG) 2014-11-25 US disclosed
US-20110171739-A1 LIGANDS FOR AGGREGATED TAU MOLECULES WISTA LABORATORIES LTD. 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110171739-A1 LIGANDS FOR AGGREGATED TAU MOLECULES MAPT, PRNP, MAP4 APP 17/4885MAPT 1/4885TP53 94/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.